Timing and sequence of vaccination against COVID-19 and influenza - Author's reply
- PMID: 37337587
- PMCID: PMC10269369
- DOI: 10.1016/j.lanepe.2023.100669
Timing and sequence of vaccination against COVID-19 and influenza - Author's reply
Conflict of interest statement
MGN is a scientific founder of TTxD, Lemba and BioTrip, and a member of the TTxD scientific advisory board. MGN has received research grants from TTxD and GSK. The TACTIC trial was conducted with the ZonMw COVID-19 programme. The other authors have no conflict of interest.
References
-
- Izikson R., Brune D., Bolduc J.-S., et al. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged≥ 65 years: a phase 2, randomised, open-label study. Lancet Respir Med. 2022;10(4):392–402. - PMC - PubMed
LinkOut - more resources
Full Text Sources